MP
PEAR

Mangrove Partners’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Mangrove Partners’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-299,693
Closed -$2.96M – 402
2021
Q2 		$2.96M Buy
+299,693
New +$2.96M 0.3% 68